{"@id":"https://bioecon.ru/technology/ai-based-ada-immunogenicity-prediction/","@type":"Technology","cluster":"bioinformatics-omics","formats":{"html":"https://bioecon.ru/technology/ai-based-ada-immunogenicity-prediction/","json":"https://bioecon.ru/api/v1/technology/ai-based-ada-immunogenicity-prediction/index.json"},"id":"ai-based-ada-immunogenicity-prediction","industries":["diagnostics","medtech-devices","pharma"],"lang":"ru","links":{"industries":["https://bioecon.ru/industries/diagnostics/","https://bioecon.ru/industries/medtech-devices/","https://bioecon.ru/industries/pharma/"],"suppliers":["https://bioecon.ru/companies/jiangsu-hengrui-medicine/","https://bioecon.ru/companies/daiichi-sankyo/","https://bioecon.ru/companies/chitose/","https://bioecon.ru/companies/genmab/","https://bioecon.ru/companies/isomorphic-labs/","https://bioecon.ru/companies/altos-labs/","https://bioecon.ru/companies/hlb-genex/","https://bioecon.ru/companies/ecowin/","https://bioecon.ru/companies/vland-biotech/","https://bioecon.ru/companies/grupo-hidrogood/"]},"maturity":7,"name":"ИИ-прогнозирование иммуногенности биопрепаратов и выработки антител против лекарств (ADA)","regions":["ch","eu","us","cn"],"risk":"low","section":"technology","sector":"health-biomedicine","sources":[{"date":"2026-11-22","entity":"Swiss Biotech Directory 2026","kind":"vendor","urls":["https://www.swissbiotech.org/directory/"]}],"stages":[{"n":1,"title":"3D картирование эпитопов биопрепарата"},{"n":2,"title":"Прогноз связывания с аллелями HLA-II"},{"n":3,"title":"Валидация на органоидах миндалин человека"},{"n":4,"title":"Деиммунизационный белковый инжиниринг"}],"summary":"Платформа машинного обучения для прогноза титров антител против лекарств (ADA), презентации эпитопов HLA-II и активации Т-клеток с валидацией на органоидах миндалин.","url":"/technology/ai-based-ada-immunogenicity-prediction/","verified":"2026-11-22"}